AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2684023
Drug: Griseofulvin 500
RxNorm normalized name: griseofulvin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Griseofulvin 500 mg daily for 6 weeks
Trial: 1097740
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg oral medrogestone twice daily
Trial: 1097740
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg oral medrogestone twice daily
Trial: 28939427
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of bacterial endotoxin lipopolysaccharide (LPS) at a dose of 2ng/kg body weight
Trial: 28939427
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of bacterial endotoxin lipopolysaccharide (LPS)
Trial: 21415778
Drug: Gefitinib 250
RxNorm normalized name: gefitinib 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib 250 mg daily alone (G)
Trial: 21415778
Drug: Gefitinib plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib plus daily oral UFT (GU)
Trial: 18316792
Drug: Docetaxel (DOC)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel (DOC) 75 mg/m² IV every 14 days for four cycles followed by doxorubicin 60 mg/m² and cyclophosphamide 600 mg/m² (AC) IV every 14 days for four cycles
Trial: 18316792
Drug: Doxorubicin 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 60 mg/m² and cyclophosphamide 600 mg/m² (AC) IV every 14 days for four cycles followed by Docetaxel (DOC) 75 mg/m² IV every 14 days for four cycles
Trial: 17159108
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D 4,000 IU/day (adults)
Trial: 17159108
Drug: Low-dose vitamin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose vitamin D 400 IU/day (adults)
Trial: 17159108
Drug: Low-dose vitamin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose vitamin D 2,000 IU/day (children/adolescents)
Trial: 17159108
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D 2,000 IU/day (children/adolescents)
Trial: 15251831
Drug: D‐chiro‐inositol 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D‐chiro‐inositol 600 mg orally once daily for 6 to 8 weeks
Trial: 2292637
Drug: Pharmacotherapy only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy only (NoCT)
Trial: 30888253
Drug: Zinc (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc (50 mg)
Trial: 30888253
Drug: Selenium (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium (200 µg)
Trial: 14641691
Drug: 300 micro
RxNorm normalized name: Voglibose 300 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 micro g nasal 17beta‐estradiol
Trial: 11053333
Drug: L-NMMA after
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA after exercise
Trial: 11053333
Drug: L-NMMA after
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA after sham
Trial: 9209787
Drug: Ceftibuten (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftibuten (400 mg daily)
Trial: 9209787
Drug: Amoxicillin/clavulanate (AMX/CA,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (AMX/CA, 500 mg/125 mg three times daily)
Trial: 9209787
Drug: Ceftibuten (once-daily)
RxNorm normalized name: Ceftibuten
DrugBank: Ceftibuten (DB01415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftibuten (once-daily)
Trial: 9209787
Drug: Ceftibuten (twice-daily)
RxNorm normalized name: Ceftibuten
DrugBank: Ceftibuten (DB01415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftibuten (twice-daily)
Trial: 7963779
Drug: Clonidine 0.150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.150 mg i.v.
Trial: 7963779
Drug: Meperidine 50
RxNorm normalized name: meperidine 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 50 mg i.v.
Trial: 31501493
Drug: Telmisartan with
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan with placebo capsules
Trial: 18285411
Drug: Pioglitazone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (30 mg/d) for 16 weeks
Trial: 11944023
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (400 IU of vitamin E, 500 mg of vitamin C, and 12 mg of beta-carotene daily)
Trial: 11944023
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (800 IU of vitamin E, 1000 mg of vitamin C, and 24 mg of beta-carotene daily)
Trial: 9743957
Drug: HIT'88/'89 regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIT'88/'89 regimen (preradiation chemotherapy)
Trial: 9743957
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen (CCNU, cisplatin, and vincristine after radiation therapy)
Trial: 8983939
Drug: Rifampicine Generic
RxNorm normalized name: rifampicin
DrugBank: Rifampin (DB01045)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifampicine Generic 300 mg capsules
Trial: 8983939
Drug: Rimactan 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimactan 300 mg capsules
Trial: 2517005
Drug: Rilmenidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilmenidine (1 mg once or twice daily)
Trial: 2517005
Drug: Clonidine (0.150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.150 mg once or twice daily)
Trial: 2517005
Drug: Rilmenidine (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilmenidine (single dose)
Trial: 9553683
Drug: Reference preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference preparation
Trial: 7325577
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg indomethacin administered six hours after blockade
Trial: 7325577
Drug: 3000 ml
RxNorm normalized name: TPN Bag 3000 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3000 ml fluid infusion during operation
Trial: 25056584
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy with 300 index of reactivity mixture of Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for 12 months
Trial: 22135048
Drug: Freeze-dried strawberry
RxNorm normalized name: BLACKBERRY MESOCARP FREEZE DRIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Freeze-dried strawberry powder at 60 g/d
Trial: 22135048
Drug: Freeze-dried strawberry
RxNorm normalized name: BLACKBERRY MESOCARP FREEZE DRIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Freeze-dried strawberry powder at 30 g/d
Trial: 9661605
Drug: Lipid (Liposyn
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid (Liposyn II; 1.5 mL/min) and heparin (0.4 U/kg.min; L/H) infusion
Trial: 9661605
Drug: Saline/glycerol (2.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline/glycerol (2.25 g/h; S/G) infusion
Trial: 2745669
Drug: Bromocriptine administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine administration during days 2-12 of ovarian hyperstimulation
Trial: 31633607
Drug: Levobupivacaine 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 0.4 mg/kg with volume adjusted to 0.2 mL/kg of 0.2% or 0.4 mL/kg of 0.1%
Trial: 31633607
Drug: Levobupivacaine 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 0.4 mg/kg
Trial: 31633607
Drug: Levobupivacaine dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine dosing regimen
Trial: 27415645
Drug: PRB exercises
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRB exercises combined with motivational group discussions twice weekly for 3 months
Trial: 26721137
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (0.3 g ibuprofen orally twice a day for 10 days)
Trial: 23320605
Drug: Selenium at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium at 0.15 mg kg(‐1)
Trial: 23320605
Drug: Selenium at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium at 0.30 mg kg(‐1)
Trial: 23320605
Drug: Selenium at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium at 0.45 mg kg(‐1)
Trial: 23320605
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 mg kg(‐1) selenium)
Trial: 19397687
Drug: Polymerized-Collagen (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polymerized-Collagen (2 mL, 12 intra-articular injections over 6 months)
Trial: 19397687
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 mL, 12 intra-articular injections over 6 months)
Trial: 12067865
Drug: ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 4 mg iv just prior to induction of anesthesia
Trial: 70931
Drug: Zinc sulphate,
RxNorm normalized name: Zinc sulphate, anhydrous
DrugBank: Zinc sulfate (DB09322)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc sulphate, 0.6 g daily for 12 weeks (some patients treated for 4 or 8 weeks)
Trial: 30930573
Drug: Ultrasound phonophoresis
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound phonophoresis therapy with Lofnac Gel (diclofenac and methyl salicylate)
Trial: 30930573
Drug: Ultrasound phonophoresis
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound phonophoresis therapy with Lofnac Gel
Trial: 21136267
Drug: Intra-umbilical oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-umbilical oxytocin 100 IU diluted in 30 ml of saline
Trial: 9338642
Drug: Pulsatile flow
RxNorm normalized name: PULSATILLA PRATENSIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsatile flow at pump flow rates of 0.6, 1.2, and 2.4 L x m2 x min(‐1)
Trial: 9338642
Drug: Nonpulsatile flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonpulsatile flow at pump flow rates of 0.6, 1.2, and 2.4 L x m2 x min(‐1)
Trial: 3318993
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg rimexolone
Trial: 3318993
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg rimexolone
Trial: 3318993
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg rimexolone
Trial: 28729473
Drug: Manual oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual oxygen titration
Trial: 16219013
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg three times daily plus a diet providing an energy deficit of 500 kcal/day
Trial: 16219013
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg three times daily plus a diet providing an energy deficit of 1000 kcal/day
Trial: 16219013
Drug: Both diet
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both diet treatment groups (500 kcal/day and 1000 kcal/day)
Trial: 7552617
Drug: Intraoperative radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative radiotherapy (IORT) with doses of 12.5-16.5 Gy
Trial: 7552617
Drug: Adjuvant external
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant external beam radiation (given to 23 of the 27 patients receiving IORT) with total doses ranging from 24 to 50 Gy
Trial: 2843201
Drug: Enalapril 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 40 mg
Trial: 2410720
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg (hypertension group)
Trial: 2410720
Drug: Enalapril 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 40 mg (hypertension group)
Trial: 27581208
Drug: initial triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: initial triple DMARD therapy (iTDT) with glucocorticoids (GCs) intramuscular
Trial: 27581208
Drug: initial triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: initial triple DMARD therapy (iTDT) with an oral GC tapering scheme
Trial: 27581208
Drug: initial MTX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: initial MTX monotherapy (iMM) with GCs
Trial: 18306849
Drug: Minimally invasive
RxNorm normalized name: SPY Minimally Invasive Surgery (SPY-MIS) Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimally invasive treatment modalities
Trial: 12892607
Drug: Transparent posterior
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transparent posterior capsule group
Trial: 10975771
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose recombinant alpha-2a interferon (9 MU thrice weekly for 6 months, followed by 6 MU for another 6 months)
Trial: 10975771
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose recombinant alpha-2a interferon (6 MU thrice weekly for 6 months, followed by 6 MU for another 6 months)
Trial: 7847866
Drug: 5% lidocaine
RxNorm normalized name: LIDOCAINE 5 g in 100 g TOPICAL CREAM [Healcome Tattoo Numbing Cream 5% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% lidocaine gel applied locally to painful skin area
Trial: 7847866
Drug: Remote application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remote application of lidocaine gel to mirror-image skin
Trial: 2128266
Drug: Standard continuous
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard continuous total parenteral nutrition (S-TPN)
Trial: 2128266
Drug: Cyclic total
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic total parenteral nutrition (C-TPN)
Trial: 7023166
Drug: Cimetidine (1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (1,200 mg daily)
Trial: 28121466
Drug: 20-week trauma-sensitive
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-week trauma-sensitive yoga treatment
Trial: 18956132
Drug: Alendronate (ALN,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (ALN, 70 mg/week) plus calcium (500 mg/daily) and vitamin D(3) (400 IU/daily)
Trial: 18956132
Drug: Calcium (500
RxNorm normalized name: calcium gluconate 45 mg calcium (500 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (500 mg/daily) and vitamin D(3) (400 IU/daily; Ca-Vit D group)
Trial: 17050216
Drug: Conventional dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dosing schedule (tablet phenytoin 100-400 mg/day OD or BD, tablet carbamazepine 200-800 mg BD, or both)
Trial: 17050216
Drug: Chronotherapeutic dosing
RxNorm normalized name: Other chemotherapeutics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronotherapeutic dosing schedule (shift of daily dose to 20:00 h)
Trial: 14656363
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) Turbohaler 1600 mcg daily
Trial: 9137496
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg x 3
Trial: 9137496
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg x 3 + Methylprednisolone 4 mg
Trial: 9137496
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg x 3 + Methylprednisolone 4 mg + Ondansetron 8 mg x 3
Trial: 2441175
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg acebutolol
Trial: 2865028
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg betaxolol
Trial: 23400742
Drug: etravirine 200
RxNorm normalized name: etravirine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etravirine 200 mg twice daily with fluconazole 200 mg daily
Trial: 23400742
Drug: etravirine 200
RxNorm normalized name: etravirine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etravirine 200 mg twice daily with voriconazole 200 mg twice daily
Trial: 18758284
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment with open reduction and internal fixation using cannulated screw or Herbert screw.
Trial: 18758284
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment with open reduction and internal fixation using cannulated screw or Herbert screw.
Trial: 23405792
Drug: Compound Xuanju
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound Xuanju Capsule plus vitamin E
Trial: 16227335
Drug: famotidine 20
RxNorm normalized name: famotidine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: famotidine 20 mg
Trial: 17502549
Drug: Modafinil (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (400 mg/day)
Trial: 15170874
Drug: High-dose dexamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dexamethasone (0.5 mg/kg/day for 3 days, 0.25 mg/kg/day for 3 days, 0.1 mg/kg/day on day 7; total dose 2.35 mg/kg)
Trial: 15170874
Drug: Low-dose dexamethasone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dexamethasone (0.2 mg/kg/day for 3 days and 0.1 mg/kg/day for 4 days; total dose 1 mg/kg)
Trial: 15170874
Drug: Comparison between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison between high-dose and low-dose dexamethasone
Trial: 8092087
Drug: 6.5 mg
RxNorm normalized name: menthol 6.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.5 mg methionine.kg‐1.d‐1 plus 0 mg cystine.kg‐1.d‐1
Trial: 8092087
Drug: 6.5 mg
RxNorm normalized name: menthol 6.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.5 mg methionine.kg‐1.d‐1 plus 5.2 mg cystine.kg‐1.d‐1
Trial: 8092087
Drug: 6.5 mg
RxNorm normalized name: menthol 6.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.5 mg methionine.kg‐1.d‐1 plus 10.5 mg cystine.kg‐1.d‐1
Trial: 8092087
Drug: 6.5 mg
RxNorm normalized name: menthol 6.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.5 mg methionine.kg‐1.d‐1 plus 20.9 mg cystine.kg‐1.d‐1
Trial: 8092087
Drug: 13 mg
RxNorm normalized name: hemin 313 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13 mg methionine.kg‐1.d‐1 without cystine
Trial: 31880338
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (UC) swallowing therapy
Trial: 23819675
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with sparse verbs
Trial: 23819675
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with dense verbs
Trial: 21365055
Drug: ITI (Institut
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ITI (Institut Straumann) implants
Trial: 21365055
Drug: SwissPlus (Zimmer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SwissPlus (Zimmer Dental) implants
Trial: 21365055
Drug: Astra (Astra
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astra (Astra Tech) implants
Trial: 19801020
Drug: Erythropoietin (EPO)
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (EPO) 30,000 IU intravenously before tenecteplase treatment
Trial: 9413414
Drug: Sertraline (50‐200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50‐200 mg daily)
Trial: 9413414
Drug: Amitriptyline (50‐150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (50‐150 mg daily)
Trial: 3781184
Drug: Cisapride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (5 mg) intravenously 15 min before meal
Trial: 3781184
Drug: Metoclopramide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (10 mg) intravenously 15 min before meal
Trial: 9506488
Drug: Midazolam (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.1 mg/kg)
Trial: 20156348
Drug: Goal-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed therapy using FloTrac/Vigileo device (GDT-group, n = 30)
Trial: 16260965
Drug: Testosterone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (100 mg of testosterone enanthate)
Trial: 14738260
Drug: Intravenous anti-D
RxNorm normalized name: anti-D (rh) immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anti-D